New International Science Center: A Tale of Two Cities

At a groundbreaking celebration last fall in Kyoto, Japan, officials of the Kyoto Research Park Corp. and Philadelphia’s University City Science Center (UCSC) watched as a Shinto priest blessed the construction site. Several months later, in March of this year, the Japanese officials visited Philadelphia and planted a symbolic cherry tree on the Science Center’s grounds. Both ceremonies were held in honor of an unprecedented agreement, formally announced at the Philadelphia tree-p

Written byRoberta Shell
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

At a groundbreaking celebration last fall in Kyoto, Japan, officials of the Kyoto Research Park Corp. and Philadelphia’s University City Science Center (UCSC) watched as a Shinto priest blessed the construction site. Several months later, in March of this year, the Japanese officials visited Philadelphia and planted a symbolic cherry tree on the Science Center’s grounds. Both ceremonies were held in honor of an unprecedented agreement, formally announced at the Philadelphia tree-planting The two corporations had joined to create Science Center International.

The agreement calls for development of a 23-acre, $600 million scientific research park in Japan’s Kansai region to serve as an incubator for new high-tech business enterprises. Osaka Gas—the official parent company of Kyoto Research Park—is contributing 70% of the capital needed for the international science center. UCSC—a nonprofit corporation promoting technology development—is providing 30%.

The developers plan 30 buildings for the site—to be completed by 1996—which they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies